Kadant Inc. — Form 10-Q Summary
Period clarification: This filing covers the quarter ended July 1, 2023, and compares results with the quarter ended July 2, 2022; it is not a 2022 Q2 filing. Amounts below are in U.S. dollars, rounded to millions unless stated otherwise. Interim results are unaudited.
Business context and reporting period
Kadant supplies technologies and engineered systems for sustainable industrial processing. Its three segments are Flow Control, Industrial Processing, and Material Handling. More than half of sales are to customers outside the United States.
Financial performance
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Revenue | $245.1m | $221.6m | $474.8m | $448.1m |
| Gross margin | 43.5% | 43.3% | 43.9% | 43.3% |
| Operating income | $43.1m | $37.5m | $83.2m | $93.4m |
| Net income attributable to Kadant | $29.7m | $26.2m | $57.8m | $67.4m |
| Diluted EPS | $2.54 | $2.24 | $4.94 | $5.77 |
| Operating cash flow | $22.5m | $18.8m | $59.3m | $42.6m |
| Free cash flow (non-GAAP) | $13.7m | $11.9m | $46.1m | $32.8m |
Q2 revenue rose 11% year over year (12% organically); reported revenue included a 1% adverse currency effect. Q2 adjusted EBITDA was $51.6m, with a 21.0% margin, versus $46.0m and 20.7% a year earlier. For the first half, adjusted EBITDA was $100.1m, with a 21.1% margin, versus $91.8m and 20.5%.
- Q2 segment revenue: Flow Control $95.7m (+12%); Industrial Processing $90.0m (+7%); Material Handling $59.4m (+14%).
- At July 1, 2023, cash and cash equivalents were $66.7m, restricted cash $3.5m, and working capital $222.4m.
- Total short- and long-term obligations were $156.9m, down from $201.2m at December 31, 2022. Revolver borrowings were $142.6m; $257.3m of the $400m facility was available, plus a separate $200m uncommitted incremental facility. The weighted-average revolver rate was 5.27%. The company reported a 0.51 leverage ratio and compliance with debt covenants.
- First-half capital expenditures were $13.2m. The company expects $25m–$27m of capital expenditures during the remainder of 2023, including $5m for its new China facility.
Changes versus comparable periods
Q2 revenue and attributable net income increased year over year, with higher revenue across all three segments. Consolidated gross margin improved modestly; segment-level performance differed, with Flow Control margin lower and Industrial Processing and Material Handling margins higher. Interest expense increased to $2.2m from $1.4m, principally because of higher rates.
First-half attributable net income declined despite revenue growth. The main comparison factor was a $20.2m pretax gain on a China facility sale recorded in Q1 2022 ($15.1m after tax); excluding that one-time gain, the year-over-year earnings comparison is materially different. First-half operating cash flow increased, mainly reflecting lower working-capital cash use.
Outlook, commentary, risks, and unusual items
- Bookings were $215.2m in Q2, down 22% sequentially from a record Q1 that included several large orders. Backlog was $362.8m, more than half in Industrial Processing. Management expects bookings for the rest of 2023 to be consistent with Q2.
- Management expects slight demand softness in Flow Control, steady Industrial Processing demand while noting uncertainty around inflation-control efforts, and steady Material Handling demand in the second half. It described the operating environment as challenging amid inflation, geopolitical tensions, labor availability, slower European growth, and contraction in Chinese manufacturing activity.
- Management expects existing cash, operating cash generation, borrowing capacity, and debt-market access to meet requirements for the next 12 months and foreseeable future. No numerical revenue or EPS guidance is provided in the supplied filing text.
- The China facility sale produced the $20.2m pretax gain in first-half 2022; relocation to a new facility was expected to be completed in the second half of 2023. Q2 2023 included $74,000 of related write-down and moving costs.
- Other exposures include currency fluctuations, tariffs on certain China imports, and ordinary-course litigation. Chinese bank acceptance drafts transferred to vendors with recourse totaled $12.3m; the company said these historically settle without recourse claims. It reported no material change in market-risk exposure and no material change in internal financial controls.
Most important facts for investors to verify
- Whether bookings and the $362.8m backlog convert to revenue and cash as expected, given management’s outlook for softer or steady demand by segment.
- The quality and sustainability of earnings growth, particularly the distinction between Q2 improvement and the prior-year China-sale gain affecting first-half comparisons.
- Debt repayment, borrowing costs, and covenant headroom as interest rates and operating conditions evolve.
- Execution, cost, and timing of the China facility relocation and planned capital spending.
- Working-capital requirements, foreign-exchange effects, tariffs, and potential recourse or litigation exposures.